05.01.2018
- Pershing Square, the hedge fund of US activist investor Bill Ackman, and Canada-based drugmaker Valeant Pharmaceuticals have agreed in principle to pay $290 million to settle two...
15.03.2017
- US activist investor Bill Ackman is pulling the plug on his Pershing Square Capital Management hedge fund’s loss-making engagement in drugmaker Valeant. After the close of trading...
25.02.2015
- With activist investors continuing to make headlines in the chemical industry, especially in the US, the struggles of Dow, DuPont and Botox producer Allergan are cases in point -...
04.11.2014
- Botox maker Allergan, which is fighting a hostile takeover bid by Valeant Pharmaceutical, is said to have been approached about a potential transaction by another party. The news...
